Source: Los Angeles Times One in every six cancer deaths worldwide is caused by preventable infections, a total of 1.5 million deaths yearly that could be halted by widespread vaccination programs, researchers reported Wednesday. Since 1990, that number has grown by about half a million, suggesting that vaccination programs are losing ground in the battle [...]
Continue reading...Monday, May 7, 2012
Source: CBC News Cost to the province estimated between $5 million and $8 million The province is considering offering boys free immunizations against the human papillomavirus. The HPV vaccination is currently offered on a voluntary basis to all girls in Alberta entering Grade 5. The vaccine is said to prevent 70 per cent of cervical [...]
Continue reading...Wednesday, May 2, 2012
Source: HemOnc Today The ongoing monitoring of HPV-associated cancers via the National Program of Cancer Registries and the Surveillance, Epidemiology and End Results program indicate a decrease in the US rates for cervical cancer, yet disparities remain, according to data published in a recent Morbidity and Mortality Weekly Report. Data pooled from the high-quality population-based [...]
Continue reading...Wednesday, April 18, 2012
Source: OncLive.com As the incidence of head and neck cancers linked to the human papillomavirus (HPV) continues to rise, a federal advisory panel has recommended that all 11- and 12-year-old boys be vaccinated against the virus, igniting further controversy in an area where acceptance of a public health policy has been slow. The recommendation from [...]
Continue reading...Tuesday, April 17, 2012
Source: abcnews.com The human papillomavirus (HPV) vaccine has been touted as a way to prevent cervical cancer and genital warts, but a new study suggests the vaccine may also prevent women diagnosed with precancers from developing recurrences. Researchers randomly assigned more than 1,350 women diagnosed with genital warts or certain precancerous conditions to receive either [...]
Continue reading...Wednesday, April 11, 2012
Source: Therapeutics Daily PORTLAND, Ore., April 3, 2012 /PRNewswire/ — Younger girls are more likely than adult women to report side effects after receiving Gardasil, the human papillomavirus vaccine. The side effects are non-serious and similar to those associated with other vaccines, according to a new study funded by the Centers for Disease Control and [...]
Continue reading...Thursday, April 5, 2012
Source: Forbes Magazine, written by Matthew Herper Neal Fowler, 50, the chief executive officer of a tiny biotech called Liquidia, was assuming a position common to road-warrior entrepreneurs: leaning his elbows on the seat-back tray in an airplane so he could gaze at the screen of his laptop. That’s when he felt the lump in [...]
Continue reading...Monday, April 2, 2012
Source: Medscape.com Human papillomavirus (HPV) vaccination substantially reduced the risk for subsequent HPV disease in women who already had 1 bout of HPV-related disease, according to a study published online today in BMJ. “These are, to our knowledge, the first results in vaccinated women who have undergone treatment for HPV-related disease,” write the authors, headed [...]
Continue reading...Tuesday, March 27, 2012
Source: Therapeutics Daily AUSTIN, Texas, March 26, 2012 /PRNewswire-USNewswire/ — Nobel Prize winner Harald zur Hausen called for vaccinating both young males and females for human papilloma virus (HPV) in an achievable quest to eradicate cervical cancer, which is the second leading type of women’s cancer worldwide. Zur Hausen made his remarks at a gathering [...]
Continue reading...Wednesday, March 21, 2012
Source: HemOnc Today The American Academy of Pediatrics Committee on Infectious Diseases issued an updated policy statement on human papillomavirus vaccination that recommends both boys and girls be immunized. The policy statement notes vaccination reduces the incidence of sexually transmitted infections and reduces cancer risk. “Persistent infection with high-risk HPV types is responsible for most [...]
Continue reading...
Wednesday, May 9, 2012
0 Comments